CEOs of genome editing companies
Name | Description | Birthdate | Birthplace | ||
|---|---|---|---|---|---|
American entrepreneur, venture capitalist, inventor, technologist, and CEO. | July 25, 1962 | ||||
Ben Lamm is an American serial software and tech entrepreneur and investor. He is the founder of Hypergiant, Conversable, Chaotic Moon Studios and Team Chaos. | January 1, 1981 | ||||
CEO of Vertex Pharmaceuticals. | 1973 | ||||
Dominic Borie, MD, PhD is Chief Executive Officer at Kyverna Therapeutics. Dr. Borie is an accomplished immunologist and digestive tract and liver transplant surgeon with extensive experience in drug development. He joins Kyverna from Horizon Therapeutics where he served as Vice-President and Head, External Research and Development. | |||||
Joe Jimenez is the Co-Founder and Managing Director at Aditum Bio. | January 1, 1959 | ||||
CEO of Bayer AG as well as chairman of the company's management board. He is additionally the company's Labor Deputy and its Chief Sustainability Officer. | October 6, 1962 | ||||
CEO of Yield10 Bioscience | |||||
CEO of CRISPR Therapeutics | |||||
Executive Chairman of the Board | |||||
Benjamin L. Oakes is the President and CEO at Scribe Therapeutics and a co-founder of the company. | |||||
CEO of Pfizer & Bamboo Therapeutics, Inc., based in New York | October 21, 1961 | ||||
Founder of Caribou Biosciences | May 20, 1985 | ||||
American businessman | January 1, 1953 | ||||
Businessperson | May 23, 1959 | ||||
Founder of Mammoth Biosciences | |||||
CEO of Sanofi | |||||
American chemist | October 20, 1936 | ||||
Co-founder and CEO or Acrigen Biosciences | |||||
Co-founder and CEO of Spark Therapeutics | |||||
CEO of Celularity, based in Virginia | |||||
Lebanese businessman | January 23, 1965 | ||||
CEO of Homology Medicines & Agilis Biotherapeutics Inc. | |||||
former CEO of BlueRock Therapeutics, based in Massachusetts | |||||
founder & CEO of Biocytogen | |||||
founder & CEO of BreezeBio |
